BSX vs SRI · P/E 20, rev $10.65B vs rev $342.2M
Boston Scientific Corp (BSX) versus Stoneridge Inc (SRI) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
Stoneridge Inc (SRI) is a auto parts company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported SRI revenue for 2026-06-30 was $342.2M. Net income was -$33.2M. SRI currently screens at market cap $221.9M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. SRI currently screens at market cap $221.9M.
Not investment advice. Open the BSX and SRI stock pages for the full models.
Not investment advice.